Residential College | false |
Status | 已發表Published |
F-18-FDG-PET/CT-guided intensity-modulated radiotherapy for 42 FIGO III/IV ovarian cancer: A retrospective study | |
Dang, Ya-Zheng1; Li, Xin1; Ma, Yu-Xin1; Li, Xiao-Long1; Yang, Ting1; Lu, Wan-Ling1; Huang, Shi-Gao1,2 | |
2019-01 | |
Source Publication | ONCOLOGY LETTERS |
ISSN | 1792-1074 |
Volume | 17Issue:1Pages:149-158 |
Abstract | The aim of the present study was to evaluate the curative effect of fludeoxyglucose-positron emission tomography/computed tomography (F-18-FDG-PET/CT)-guided intensity-modulated radiotherapy (IMRT) for 42 patients with International Federation of Gynecology and Obstetrics (FIGO) stage III/IV ovarian cancer. Between January 2012 and December 2015, 42 patients with FIGO stage III/IV ovarian cancer who were treated with F-18-FDG-PET/CT-guided IMRT at the Department of Radiation Oncology were analyzed. A total of 21 patients who exhibited recurrence following surgery and 11 patients who were unable to tolerate or rejected surgery received 5-10 cycles of chemotherapy only. A total of 10 patients, who were either older (>70 years) or in poor general health were unable to undergo surgery and only received IMRT. The patients received a total radiation dose of 5,040 cGy (range, 4,500-5,500 cGy), with a dose fraction of 200 cGy/fx, administered a total of 10-14 times, 5 times/week, prior to being rested for half an hour to relocate lesions and undergoing a second round of radiotherapy for 10-14 cycles. The 1-, 2- and 3-year progression-free survival (PFS) rates of the patients were 66.7, 33.3 and 21.4%, respectively, and the median PFS time was 20.3 months. The 1-, 2- and 3-year local control rates of the patients were 90.5, 83.3 and 69.0%, respectively, and the 1-, 2- and 3-year overall survival (OS) rates were 73.8, 64.3 and 52.4%, respectively. According to the results of multivariate analysis using the Cox proportional hazards model, the Karnofsky performance status (KPS) score (1) was the only index associated with prognosis (P<0.003). The study concluded that for patients with advanced ovarian cancer, particularly for patients unable to undergo surgery or chemotherapy, F-18-FDG PET/CT-guided IMRT is a safe and effective treatment method, and it may be considered as an equally effective treatment option. Furthermore, the results of the present study suggested that the KPS score of a patient is the only factor affecting the OS time. |
Keyword | Ovarian Cancer Radiation Therapy Positron Emission Tomography Computed Tomography Intensity-modulated Radiotherapy |
DOI | 10.3892/ol.2018.9601 |
URL | View the original |
Indexed By | SCIE |
Language | 英語English |
WOS Research Area | Oncology |
WOS Subject | Oncology |
WOS ID | WOS:000454845500019 |
Publisher | SPANDIDOS PUBL LTD |
Scopus ID | 2-s2.0-85057506232 |
Fulltext Access | |
Citation statistics | |
Document Type | Journal article |
Collection | University of Macau |
Affiliation | 1.Peoples Liberat Army Air Force, Hosp 986, Dept Radiat Oncol, Xian 710054, Shaanxi, Peoples R China; 2.Univ Macau, Fac Hlth Sci, Ave Univ, Taipa, Macao, Peoples R China |
Recommended Citation GB/T 7714 | Dang, Ya-Zheng,Li, Xin,Ma, Yu-Xin,et al. F-18-FDG-PET/CT-guided intensity-modulated radiotherapy for 42 FIGO III/IV ovarian cancer: A retrospective study[J]. ONCOLOGY LETTERS, 2019, 17(1), 149-158. |
APA | Dang, Ya-Zheng., Li, Xin., Ma, Yu-Xin., Li, Xiao-Long., Yang, Ting., Lu, Wan-Ling., & Huang, Shi-Gao (2019). F-18-FDG-PET/CT-guided intensity-modulated radiotherapy for 42 FIGO III/IV ovarian cancer: A retrospective study. ONCOLOGY LETTERS, 17(1), 149-158. |
MLA | Dang, Ya-Zheng,et al."F-18-FDG-PET/CT-guided intensity-modulated radiotherapy for 42 FIGO III/IV ovarian cancer: A retrospective study".ONCOLOGY LETTERS 17.1(2019):149-158. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment